NASDAQ: PROFProfound Medical Corp Stock Ownership - Who owns Profound Medical?
Insider buying vs selling
Have Profound Medical Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Arun Swarup Menawat | CEO | 2025-05-16 | 12,027 | $4.73 | $56.89kBuy |
| Arun Swarup Menawat | CEO | 2025-05-15 | 10,003 | $4.33 | $43.26kBuy |
PROF insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PROF insiders and whales buy or sell their stock.
PROF Shareholders
What type of owners hold Profound Medical Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fil Ltd | 6.06% | 2,200,000 | $12.21M | Institution |
| Gagnon Securities LLC | 5.36% | 1,944,061 | $10.79M | Institution |
| Rosalind Advisors Inc | 2.95% | 1,068,955 | $5.93M | Institution |
| Royce Associates LP | 2.73% | 990,348 | $5.50M | Institution |
| Timelo Investment Management Inc | 2.70% | 979,967 | $5.44M | Institution |
| Letko Brosseau Associates Inc | 2.67% | 970,675 | $5.39M | Institution |
| Gagnon Advisors LLC | 2.65% | 962,186 | $5.34M | Institution |
| Alyeska Investment Group LP | 1.87% | 678,570 | $3.77M | Institution |
| Arun Swarup Menawat | 1.62% | 587,089 | $3.26M | Insider |
| Mmcap International Inc Spc | 1.46% | 531,362 | $2.95M | Institution |
PROF vs Medical Device Stocks
Profound Medical Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.